Skin Laboratory PCL (BKK:SKIN)
Thailand
· Delayed Price · Currency is THB 1.140
+0.010 (0.88%)
Last updated: Mar 10, 2026, 11:27 AM ICT
Skin Laboratory PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Operating Revenue | 176.73 | 229.13 | 271.8 | 282.12 | 197.55 | Upgrade
|
| Other Revenue | 2.23 | 1.4 | 0.99 | 0.58 | 1.03 | Upgrade
|
| Revenue | 178.96 | 230.53 | 272.8 | 282.7 | 198.57 | Upgrade
|
| Revenue Growth (YoY) | -22.37% | -15.49% | -3.50% | 42.37% | 17.80% | Upgrade
|
| Cost of Revenue | 49.53 | 57.5 | 63.23 | 70.65 | 65.56 | Upgrade
|
| Gross Profit | 129.43 | 173.03 | 209.56 | 212.05 | 133.02 | Upgrade
|
| Selling, General & Admin | 123.69 | 159.5 | 188.28 | 196.86 | 96.43 | Upgrade
|
| Operating Expenses | 123.69 | 159.5 | 188.28 | 196.86 | 96.43 | Upgrade
|
| Operating Income | 5.74 | 13.53 | 21.28 | 15.19 | 36.59 | Upgrade
|
| Interest Expense | -0.15 | -0.25 | -0.19 | -0.18 | -0.18 | Upgrade
|
| EBT Excluding Unusual Items | 5.59 | 13.28 | 21.1 | 15.01 | 36.41 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.25 | -0.07 | - | - | Upgrade
|
| Pretax Income | 5.59 | 13.53 | 21.02 | 15.01 | 36.41 | Upgrade
|
| Income Tax Expense | 1.21 | 2.86 | 4.24 | 3.15 | 7.64 | Upgrade
|
| Net Income | 4.38 | 10.67 | 16.79 | 11.86 | 28.77 | Upgrade
|
| Net Income to Common | 4.38 | 10.67 | 16.79 | 11.86 | 28.77 | Upgrade
|
| Net Income Growth | -58.97% | -36.44% | 41.59% | -58.80% | 0.10% | Upgrade
|
| Shares Outstanding (Basic) | 113 | 43 | 2 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 113 | 43 | 2 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 162.19% | 2048.36% | - | - | - | Upgrade
|
| EPS (Basic) | 0.04 | 0.25 | 8.39 | 5.93 | 14.39 | Upgrade
|
| EPS (Diluted) | 0.04 | 0.25 | 8.39 | 5.93 | 14.39 | Upgrade
|
| EPS Growth | -84.35% | -97.04% | 41.59% | -58.80% | - | Upgrade
|
| Free Cash Flow | 11.97 | 3.57 | 26.25 | 4.62 | 10.87 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.08 | 13.12 | 2.31 | 5.43 | Upgrade
|
| Dividend Per Share | - | 27.580 | 7.500 | 8.000 | 6.830 | Upgrade
|
| Dividend Growth | - | 267.73% | -6.25% | 17.13% | 1.19% | Upgrade
|
| Gross Margin | 72.32% | 75.06% | 76.82% | 75.01% | 66.98% | Upgrade
|
| Operating Margin | 3.21% | 5.87% | 7.80% | 5.37% | 18.42% | Upgrade
|
| Profit Margin | 2.45% | 4.63% | 6.15% | 4.19% | 14.49% | Upgrade
|
| Free Cash Flow Margin | 6.69% | 1.55% | 9.62% | 1.63% | 5.47% | Upgrade
|
| EBITDA | 6.2 | 14.43 | 21.62 | 15.61 | 37.03 | Upgrade
|
| EBITDA Margin | 3.47% | 6.26% | 7.93% | 5.52% | 18.65% | Upgrade
|
| D&A For EBITDA | 0.46 | 0.9 | 0.34 | 0.42 | 0.44 | Upgrade
|
| EBIT | 5.74 | 13.53 | 21.28 | 15.19 | 36.59 | Upgrade
|
| EBIT Margin | 3.21% | 5.87% | 7.80% | 5.37% | 18.42% | Upgrade
|
| Effective Tax Rate | 21.72% | 21.16% | 20.16% | 20.99% | 20.97% | Upgrade
|
| Revenue as Reported | 178.96 | 230.53 | 272.8 | 282.7 | 198.57 | Upgrade
|
| Advertising Expenses | 89.63 | 123.68 | 150.16 | - | 48.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.